Schultz KR - Search Results

1

Evaluation for synergistic suppression of T cell responses to minor histocompatibility antigens by chloroquine in combination with tacrolimus and a rapamycin derivative, SDZ-RAD.

Hsiao CC, Su WN, Forooghian F, Bader S, Rempel J, HayGlass KT, Gilman A, Schultz KR. Hsiao CC, et al. Among authors: schultz kr. Bone Marrow Transplant. 2002 Dec;30(12):905-13. doi: 10.1038/sj.bmt.1703727. Bone Marrow Transplant. 2002. PMID: 12476284

2

The role of B cells for in vivo T cell responses to a Friend virus-induced leukemia.

Schultz KR, Klarnet JP, Gieni RS, HayGlass KT, Greenberg PD. Schultz KR, et al. Science. 1990 Aug 24;249(4971):921-3. doi: 10.1126/science.2118273. Science. 1990. PMID: 2118273

3

Chloroquine treatment affects T-cell priming to minor histocompatibility antigens and graft-versus-host disease.

Schultz KR, Bader S, Paquet J, Li W. Schultz KR, et al. Blood. 1995 Dec 1;86(11):4344-52. Blood. 1995. PMID: 7492796 Free article.

4

Requirement for B cells in T cell priming to minor histocompatibility antigens and development of graft-versus-host disease.

Schultz KR, Paquet J, Bader S, HayGlass KT. Schultz KR, et al. Bone Marrow Transplant. 1995 Aug;16(2):289-95. Bone Marrow Transplant. 1995. PMID: 7581150

5

Synergy between lysosomotropic amines and cyclosporin A on human T cell responses to an exogenous protein antigen, tetanus toxoid.

Schultz KR, Nelson D, Bader S. Schultz KR, et al. Bone Marrow Transplant. 1996 Sep;18(3):625-31. Bone Marrow Transplant. 1996. PMID: 8879628

6

The lysosomotropic amines, chloroquine and hydroxychloroquine: a potentially novel therapy for graft-versus-host disease.

Schultz KR, Gilman AL. Schultz KR, et al. Leuk Lymphoma. 1997 Jan;24(3-4):201-10. doi: 10.3109/10428199709039008. Leuk Lymphoma. 1997. PMID: 9156650 Review.

7

Immune suppression by lysosomotropic amines and cyclosporine on T-cell responses to minor and major histocompatibility antigens: does synergy exist?

Schultz KR, Bader S, Nelson D, Wang MD, HayGlass KT. Schultz KR, et al. Transplantation. 1997 Oct 15;64(7):1055-65. doi: 10.1097/00007890-199710150-00019. Transplantation. 1997. PMID: 9381529

8

Hydroxychloroquine for the treatment of chronic graft-versus-host disease.

Gilman AL, Chan KW, Mogul A, Morris C, Goldman FD, Boyer M, Cirenza E, Mazumder A, Gehan E, Cahill R, Frankel S, Schultz K. Gilman AL, et al. Biol Blood Marrow Transplant. 2000;6(3A):327-34. doi: 10.1016/s1083-8791(00)70058-9. Biol Blood Marrow Transplant. 2000. PMID: 10905770 Free article. Clinical Trial.

9

Treatment of chronic GVHD.

Gilman AL, Schultz KR. Gilman AL, et al. Among authors: schultz kr. Bone Marrow Transplant. 2000 Aug;26(4):460-2. doi: 10.1038/sj.bmt.1702530. Bone Marrow Transplant. 2000. PMID: 10982297 No abstract available.

10

ETV6 (TEL)-AML1 pre-B acute lymphoblastic leukaemia cells are associated with a distinct antigen-presenting phenotype.

Alessandri AJ, Reid GS, Bader SA, Massing BG, Sorensen PH, Schultz KR. Alessandri AJ, et al. Among authors: schultz kr. Br J Haematol. 2002 Feb;116(2):266-72. Br J Haematol. 2002. PMID: 11841426 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters